As of September 30, 2026, Achyut Healthcare Ltd. carries a market capitalization of 1.46B, placing it among publicly traded companies globally. Its enterprise value stands at 1.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.46B |
| Enterprise Value | 1.46B |
As of September 30, 2026, Achyut Healthcare Ltd. has 241.36M shares outstanding.
| Shares Outstanding | 241.36M |
As of September 30, 2026, Achyut Healthcare Ltd. trades at a trailing price-to-earnings ratio of 571.76. The price-to-sales ratio is 13.50, and the price-to-book ratio stands at 4.13.
| PE Ratio | 571.76 |
| PS Ratio | 13.50 |
| PB Ratio | 4.13 |
| P/TBV Ratio | 4.13 |
As of September 30, 2026, Achyut Healthcare Ltd. trades at an EV/EBITDA multiple of 609.53 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 13.55 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 2,475.45 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.46B versus a market cap of 1.46B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 13.55 |
| EV / EBITDA | 609.53 |
| EV / EBIT | 2,475.45 |
As of September 30, 2026, Achyut Healthcare Ltd. maintains a current ratio of 1.72, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.09, indicating elevated leverage, while an interest coverage ratio of 4.16 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.72 |
| Quick Ratio | 0.40 |
| Debt / Equity | 4.09 |
| Debt / EBITDA | 6.04 |
| Interest Coverage | 4.16 |
These figures cover the twelve months ended September 30, 2026. The company generates approximately 15.35M in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers.
| Revenue Per Employee | 15.35M |
| Employee Count | 7.00 |
Over the twelve months ended September 30, 2026, Achyut Healthcare Ltd. recorded 690,000.00 in income tax expense. That works out to an effective tax rate of 21.40, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.23M, leaving 2.54M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | 690,000.00 |
| Effective Tax Rate | 21.40 |
As of the close on November 17, 2026, Achyut Healthcare Ltd.'s stock has gained approximately 29.07% over the past 52 weeks. The 50-day moving average sits at 6.78, while the 200-day moving average is 6.37.
| 52-Week Price Change | 29.07% |
| 50-Day Moving Average | 6.78 |
| 200-Day Moving Average | 6.37 |
Over the twelve months ended September 30, 2026, Achyut Healthcare Ltd. generated 107.44M in revenue and converted that into 2.54M in net income, yielding earnings per share of 0.01. EBITDA reached 2.39M, while operating income came in at 588,000.00.
| Revenue | 107.44M |
| Gross Profit | 18.73M |
| Operating Income | 588,000.00 |
| Pretax Income | 3.23M |
| Net Income | 2.54M |
| EBITDA | 2.39M |
| EBIT | 588,000.00 |
| Earnings Per Share (EPS) | 0.01 |
As of September 30, 2026, Achyut Healthcare Ltd. holds 14.26M in cash and equivalents against 14.43M in total debt, resulting in a net debt position of -14.25M. Total book value stands at 352.54M, with working capital of 26.08M providing operational flexibility.
| Cash & Cash Equivalents | 14.26M |
| Total Debt | 14.43M |
| Net Debt | -14.25M |
| Equity (Book Value) | 352.54M |
| Book Value Per Share | 1.46 |
| Working Capital | 26.08M |
Over the twelve months ended September 30, 2026, Achyut Healthcare Ltd. posted a gross margin of 17.44, reflecting its pricing power and cost economics. The operating margin of 0.55 and net profit margin of 2.36 provide insight into operational efficiency.
| Gross Margin | 17.44 |
| Operating Margin | 0.55 |
| Pretax Margin | 3.00 |
| Profit Margin | 2.36 |
| EBITDA Margin | 2.22 |
Achyut Healthcare Ltd.'s most recent stock split took place on December 10, 2024 with a 1:14 split ratio.
| Last Split Date | 12/10/2024 |
| Split Ratio | 1:14 |
Already premium?